NASDAQ:HQY - Healthequity Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$85.30 +0.75 (+0.89 %)
(As of 11/19/2018 09:12 AM ET)
Previous Close$84.55
Today's Range$82.72 - $86.0150
52-Week Range$42.92 - $101.58
Volume664,303 shs
Average Volume776,787 shs
Market Capitalization$5.29 billion
P/E Ratio157.96
Dividend YieldN/A
HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only investment advisory services through Advisor, a Web-based tool. In addition, the company offers health reimbursement and flexible spending arrangements solutions; and Employee Retirement Income Security Act's plan administration and investment services. HealthEquity, Inc. was founded in 2002 and is headquartered in Draper, Utah.

Receive HQY News and Ratings via Email

Sign-up to receive the latest news and ratings for HQY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Business services, not elsewhere classified
Current SymbolNASDAQ:HQY
Previous Symbol


Debt-to-Equity RatioN/A
Current Ratio19.91
Quick Ratio19.90


Trailing P/E Ratio157.96
Forward P/E Ratio98.05
P/E Growth2.96

Sales & Book Value

Annual Sales$229.52 million
Price / Sales23.06
Cash Flow$0.8141 per share
Price / Cash104.78
Book Value$5.71 per share
Price / Book14.94


EPS (Most Recent Fiscal Year)$0.54
Net Income$47.36 million
Net Margins23.81%
Return on Equity12.58%
Return on Assets11.89%


Outstanding Shares62,050,000
Market Cap$5.29 billion

Healthequity (NASDAQ:HQY) Frequently Asked Questions

What is Healthequity's stock symbol?

Healthequity trades on the NASDAQ under the ticker symbol "HQY."

How were Healthequity's earnings last quarter?

Healthequity Inc (NASDAQ:HQY) posted its quarterly earnings data on Tuesday, September, 4th. The company reported $0.34 EPS for the quarter, beating the Zacks' consensus estimate of $0.22 by $0.12. The business earned $71.10 million during the quarter, compared to analysts' expectations of $69.84 million. Healthequity had a return on equity of 12.58% and a net margin of 23.81%. The business's revenue was up 25.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.27 earnings per share. View Healthequity's Earnings History.

When is Healthequity's next earnings date?

Healthequity is scheduled to release their next quarterly earnings announcement on Tuesday, December 4th 2018. View Earnings Estimates for Healthequity.

How can I listen to Healthequity's earnings call?

Healthequity will be holding an earnings conference call on Tuesday, December 4th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8447916252.

What guidance has Healthequity issued on next quarter's earnings?

Healthequity updated its FY19 earnings guidance on Tuesday, September, 4th. The company provided earnings per share (EPS) guidance of $0.98-1.05 for the period, compared to the Thomson Reuters consensus estimate of $0.92. The company issued revenue guidance of $279-285 million, compared to the consensus revenue estimate of $282.50 million.

What price target have analysts set for HQY?

12 equities research analysts have issued 12-month target prices for Healthequity's stock. Their predictions range from $69.00 to $110.00. On average, they expect Healthequity's stock price to reach $95.1667 in the next twelve months. This suggests a possible upside of 11.6% from the stock's current price. View Analyst Price Targets for Healthequity.

What is the consensus analysts' recommendation for Healthequity?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthequity in the last year. There are currently 3 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Healthequity.

What are Wall Street analysts saying about Healthequity stock?

Here are some recent quotes from research analysts about Healthequity stock:
  • 1. According to Zacks Investment Research, "Health Equity outperformed its industry in a year’s time. With strong Health Savings Account (HSA) member growth, the company is currently the third largest HSA custodian by market share. In addition to HSA, HealthEquity now offers health reimbursement arrangement (HRA) and a health flexible spending account (FSA) to regional employers. Apart from this, HealthEquity’s 401(K) solution that reduces the cost, risk and work of managing a retirement plan buoys optimism. By the end of the first quarter of fiscal 2019, management was optimistic regarding the launch of HealthEquity retirement services. However, the company faces stiff competition in the Medical Services markets. The company is required to comply with strict Treasury Regulations formulated by the Internal Revenue Service or the IRS. The stock looks a bit overvalued at the moment. On the brighter side, The company" (8/7/2018)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on HQY shares and increase our price target to $68 from $65. After the close on Monday, June 4, HQY reported solid 1QFY19 (ended April) results that were above FactSet consensus and our estimates. Adjusted EPS were $0.31 vs. our estimate of $0.27. The company raised its FY19 revenue and EPS guidance yet again at it continues to gain market share (number of accounts and assets). We believe HQY remains well positioned due to its strong platform and continued adoption of high-deductible health plans and HSAs." (6/4/2018)

Has Healthequity been receiving favorable news coverage?

Press coverage about HQY stock has been trending very positive this week, according to InfoTrie. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Healthequity earned a coverage optimism score of 3.2 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next few days.

Who are some of Healthequity's key competitors?

Who are Healthequity's key executives?

Healthequity's management team includes the folowing people:
  • Mr. Jon Kessler, Pres, CEO & Director (Age 50)
  • Mr. Darcy G. Mott, Exec. VP & CFO (Age 65)
  • Ms. Ashley Dreier, Exec. VP, CTO & Chief Information Officer (Age 45)
  • Mr. William Robert Otten, Exec. VP of Sales (Age 53)
  • Mr. Edward Bloomberg, Exec. VP & COO (Age 42)

Who are Healthequity's major shareholders?

Healthequity's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.73%), FMR LLC (5.62%), Janus Henderson Group PLC (4.13%), Wasatch Advisors Inc. (2.54%), Eagle Asset Management Inc. (1.73%) and Bamco Inc. NY (1.70%). Company insiders that own Healthequity stock include Adrian T Dillon, Angelique Christine Hill, Ashley Dreier, Berkley Capital, Llc, Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Corvino, Frank Medici, Gary D Robinson, Jon Kessler, Jon Soldan, Manu S Rana and Stephen Neeleman. View Institutional Ownership Trends for Healthequity.

Which major investors are selling Healthequity stock?

HQY stock was sold by a variety of institutional investors in the last quarter, including Berkley W R Corp, BlackRock Inc., Wasatch Advisors Inc., Bamco Inc. NY, Amussen Hunsaker Associates LLC, Franklin Resources Inc., Wells Fargo & Company MN and Dimensional Fund Advisors LP. Company insiders that have sold Healthequity company stock in the last year include Angelique Christine Hill, Ashley Dreier, Berkley Capital, Llc, Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Medici, Gary D Robinson, Jon Kessler, Jon Soldan and Stephen Neeleman. View Insider Buying and Selling for Healthequity.

Which major investors are buying Healthequity stock?

HQY stock was purchased by a variety of institutional investors in the last quarter, including Mirae Asset Global Investments Co. Ltd., Pictet Asset Management Ltd., Bank of New York Mellon Corp, Renaissance Technologies LLC, First Quadrant L P CA, Retirement Systems of Alabama, American International Group Inc. and Deutsche Bank AG. View Insider Buying and Selling for Healthequity.

How do I buy shares of Healthequity?

Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Healthequity's stock price today?

One share of HQY stock can currently be purchased for approximately $85.30.

How big of a company is Healthequity?

Healthequity has a market capitalization of $5.29 billion and generates $229.52 million in revenue each year. The company earns $47.36 million in net income (profit) each year or $0.54 on an earnings per share basis. Healthequity employs 1,027 workers across the globe.

What is Healthequity's official website?

The official website for Healthequity is

How can I contact Healthequity?

Healthequity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at 801-727-1000 or via email at [email protected]

MarketBeat Community Rating for Healthequity (NASDAQ HQY)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  297 (Vote Outperform)
Underperform Votes:  233 (Vote Underperform)
Total Votes:  530
MarketBeat's community ratings are surveys of what our community members think about Healthequity and other stocks. Vote "Outperform" if you believe HQY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HQY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/19/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel